Top compounds associated with response to NREP


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA linifanib GDSC1000 pan-cancer AAC 0.17 2e-05
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA FH535 GDSC1000 pan-cancer AAC -0.17 3e-05
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA GW-2580 GDSC1000 pan-cancer AAC 0.17 4e-05
mRNA AT7867 CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA XMD14-99 GDSC1000 pan-cancer AAC 0.16 5e-05
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 5e-05
Download CSV